Quick Take: Don't Be Stunned by TASER

Another day, another miss. This time, Motley Fool Rule Breakers pick TASER (Nasdaq: TASR  ) announced that its record $15 million in first-quarter revenue fell short of estimates because of delays in three large orders.

Does that sound awful? Sure. Trouble is, it's not really news. Allow me to quote from the risks section of TASER's latest 10-K annual report:

"Most of our end-user customers are government agencies. These agencies often do not set their own budgets and therefore have little control over the amount of money they can spend. In addition, these agencies experience political pressure that may dictate the manner in which they spend money. As a result, even if an agency wants to acquire our products, it may be unable to purchase them due to budgetary or political constraints. Some government agency orders may also be canceled or substantially delayed due to budgetary, political or other scheduling delays which frequently occur in connection with the acquisition of products by such agencies." [Emphasis mine.]

Here's my point. Anyone who was stunned by these delays either (a) doesn't know the business very well or (b) wasn't paying attention. Like Lockheed Martin (NYSE: LMT  ) , Boeing (NYSE: BA  ) , Northrop Grumman (NYSE: NOC  ) , and Raytheon (NYSE: RTN  ) , TASER is a defense contractor. It will profit most when the governments with which it does business are ready to spend money.

Have a different take? Let me know.

How great is growth? Four of the dozens of stocks in the market-beating Motley Fool Rule Breakers portfolio have more than doubled in two years. Care to find out who they are? Click here to get 30 days of free access to the service.

Fool contributor Tim Beyers has never been stunned by a TASER and doesn't plan to be, either. Tim didn't own shares in any of the companies mentioned in this article at the time of publication. The Motley Fool's disclosure policy was shocked -- SHOCKED -- to read that Keith Richards had once snorted his father's ashes. Is there anything he hasn't snorted?


Read/Post Comments (0) | Recommend This Article (52)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 525040, ~/Articles/ArticleHandler.aspx, 7/28/2014 9:02:48 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement